Trial intelligence / Profile preview

Forteo for femoral neck fracture healing

NCT01473602Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Jan 2012
Primary completion
Nov 2013
Countries
14
01

Overview

A Phase 3 trial of teriparatide in femoral neck fracture, sponsored by Eli Lilly and Company. Started Jan 2012; status: completed.

02

Drugs

teriparatide
03

Conditions

femoral neck fracture

Beyond the preview

Go deeper on NCT01473602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01473602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call